• Retrotope’s RT001 Reduced Cognitive Defects in Mice with Huntington’s Disease, Study Shows
  • Improved Genetic Testing Protocols Should be Available for Huntington’s Disease, Study Contends
  • Skyhawk, Celgene Partner to Develop Small Molecule Treatments for Huntington’s, Other Neurological Diseases
  • Scotland’s Fife Launches Groundbreaking Local Care Frameworks for Huntington’s Disease
  • Experts Seeking Tools to Assess Effectiveness of Targeted Huntington’s Therapies
  • Dysfunction of Astrocyte Brain Cells Plays Key Role in Huntington’s, Mouse Study Suggests
  • New Huntingtin Protein Strategy Significantly Improves Symptoms Over Time, Study Finds
  • Defective Protein in Huntington’s Linked to Heart Dysfunction in Mouse Study
  • Huntington’s Protein Levels in Saliva May Work as Biomarker for Disease Worsening, Study Suggests
  • Novel Spotlights Daily Struggles of Patients and Families
  • Program Provides Second Opinion About Rare Disease Diagnosis, Care
  • Canada Trails US in Patient Access to Rare Disease Therapies, CORD President Says